Curis, Inc. (CRIS) to Present at Upcoming Investor Conferences
9/4/2013 9:48:32 AM
LEXINGTON, Mass., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused drug development company seeking to develop novel drug candidates for the treatment of human cancers, today announced that members of its executive management team will present at the following upcoming conferences:
Help employers find you! Check out all the jobs and post your resume.
comments powered by